Abolis Biotechnologies
French tech company | Builders Republic
About
Synthetic-biology company that engineers micro-organisms to produce chemical molecules by fermentation of renewable resources instead of petrochemicals — running on-demand strain development and bioprocesses for bio-based ingredients across cosmetics, food, and healthcare.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2014
- City
- EVRY-COURCOURONNES
- Region
- IDF
- Legal name
- ABOLIS BIOTECHNOLOGIES
- SIREN
- 801679614
- Tracked rounds
- 1
- Amount raised
- 35 M€ raised since 2020
Funding rounds
- Series A — 2024
Investors
- BOLD
- Evonik